| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 2,000 shares
@ $8.63, valued at
$17.3k
|
|
| 09/28/2023 |
4
| Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 600 shares
@ $8.71, valued at
$5.2k
|
|
| 08/24/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 1,000 shares
@ $9.97, valued at
$10k
|
|
| 08/21/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/14/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 08/08/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 2,000 shares
@ $10.55, valued at
$21.1k
|
|
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 1,000 shares
@ $11.69, valued at
$11.7k
|
|
| 05/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/16/2023 |
4
| Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 250 shares
@ $12.71, valued at
$3.2k
|
|
| 03/13/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 1,000 shares
@ $12.12, valued at
$12.1k
|
|
| 03/13/2023 |
8-K
| Other Events Interactive Data |
| 02/28/2023 |
4
| Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 250 shares
@ $15.395, valued at
$3.8k
|
|
| 02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 1,000 shares
@ $18.68, valued at
$18.7k
|
|
| 02/07/2023 |
4
| Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 250 shares
@ $20.84, valued at
$5.2k
|
|
| 01/31/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 2,000 shares
@ $19.35, valued at
$38.7k
|
|
| 01/30/2023 |
4
| Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 250 shares
@ $19.2, valued at
$4.8k
|
|
| 01/24/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 1,500 shares
@ $17.37, valued at
$26.1k
|
|
| 01/17/2023 |
4
| Thompson Jaye (VP Clinical Reg Affairs) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 250 shares
@ $16.5, valued at
$4.1k
|
|
| 01/10/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 1,500 shares
@ $15.18, valued at
$22.8k
|
|
| 01/03/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 4,000 shares
@ $15.19, valued at
$60.8k
|
|
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2022 |
8-K
| Quarterly results |
| 12/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
|